Sphera Funds Management’s PHAXIAM Therapeutics S.A.. American Depositary Shares PHXM Stock Holding History

Sphera Funds Management’s Portfolio PHXM Stock Details PHXM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-11,784	Closed	-$523K	–	99
2019 Q3	$523K	Sell	11,784 -120	-1%	-$6.82K	0.08%	76
2019 Q2	$853K	Sell	11,904 -96	-0.8%	-$7.07K	0.12%	79
2019 Q1	$912K	Hold	12,000	–	–	0.08%	94
2018 Q4	$796K	Hold	12,000	–	–	0.09%	90
2018 Q3	$1.05M	Buy	+12,000	New	+$1.25M	0.12%	93
2018 Q2	–	Sell	-12,000	Closed	-$2.52M	–	134
2018 Q1	$2.52M	Hold	12,000	–	–	0.38%	70
2017 Q4	$2.64M	Buy	+12,000	New	+$2.83M	0.31%	79

Other funds holding PHXM

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Sphera Funds Management's PHXM Position: Q4 2019 in Review

Sphera Funds Management sold out of PHAXIAM Therapeutics S.A.. American Depositary Shares (PHXM) in Q4 2019, closing a stake of 11,784 shares — an estimated $523K sold.

Sphera Funds Management first reported a position in PHXM in Q4 2017 and held it in 7 quarters. The position peaked at $2.64M in Q4 2017. 4 funds tracked by Wall St. Rank hold PHXM as of Q4 2019.

Sphera Funds Management reported no remaining PHAXIAM Therapeutics S.A.. American Depositary Shares position as of Q4 2019 after selling out during the quarter.
Sphera Funds Management sold 11,784 PHAXIAM Therapeutics S.A.. American Depositary Shares shares in Q4 2019, an estimated $523K.
Sphera Funds Management first reported a position in PHAXIAM Therapeutics S.A.. American Depositary Shares in Q4 2017 and held it in 7 quarters.
Sphera Funds Management's PHAXIAM Therapeutics S.A.. American Depositary Shares position peaked at $2.64M in Q4 2017.
4 funds tracked by Wall St. Rank held PHAXIAM Therapeutics S.A.. American Depositary Shares as of Q4 2019.

Based on Sphera Funds Management's 13F filing for Q4 2019, filed 13 Feb 2020.